[1]郝倩云,刘 晴,王智峰,等.胃MALT淋巴瘤一例诊治体会[J].郑州大学学报(医学版),2017,(01):98-101.[doi:10.13705/j.issn.1671-6825.2017.01.026]
点击复制

胃MALT淋巴瘤一例诊治体会()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2017年01期
页码:
98-101
栏目:
临床报道
出版日期:
2017-01-15

文章信息/Info

作者:
郝倩云刘 晴王智峰刘玉兰蒋 绚#
北京大学人民医院消化科 北京 100044
关键词:
胃MALT淋巴瘤 根除Hp 化疗
DOI:
10.13705/j.issn.1671-6825.2017.01.026

参考文献/References:

[1] NAKAMURA S,MATSUMOTO T.Treatment strategy for gastric mucosa-associated lymphoid tissue lymphoma[J].Gastroenterol Clin North Am,2015,44(3):649
[2] KOLVE M,FISCHBACH W,GREINER A,et al.Differences in endoscopic and clinicopathological features of primary and secondary gastric non-Hodgkin's lymphoma. German Gastrointestinal Lymphoma Study Group[J].Gastrointest Endosc,1999,49(3 Pt 1):307
[3] NAKAMURA S,SUGIYAMA T,MATSUMOTO T,et al.Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan[J].Gut,2012,61(4):507
[4] 刘文忠,谢勇,成虹,等.第四次全国幽门螺杆菌感染处理共识报告[J].胃肠病学, 2012,17(10):618
[5] FISCHBACH W.Gastric MALT lymphoma-update on diagnosis and treatment[J].Best Pract Res Clin Gastroenterol,2014,28(6):1069
[6] RADASZKIEWICZ T,DRAGOSICS B,BAUER P.Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis[J].Gastroenterology,1992,102(5):1628
[7] NAKAMURA S,YAO T,AOYAGI K,et al.Helicobacter pylori and primary gastric lymphoma.A histopathologic and immunohistochemical analysis of 237 patients[J].Cancer,1997,79(1):3
[8] MONTALBAN C,SANTÓN A,REDONDO C,et al.Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication.Lack of association with translocation t(11; 18): a 10-year updated follow-up of a prospective study[J].Ann Oncol,2005,16(9):1539
[9] FISCHBACH W,GOEBELER-KOLVE ME,DRAGOSICS B,et al.Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue(MALT)following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series[J].Gut,2004,53(1):34
[10]DE JONG D,VYTH-DREESE F,DELLEMIJN T,et al.Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma[J].J Pathol,2001,193(3):318
[11]ZULLO A,HASSAN C,CRISTOFARI F,et al.Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma[J].Clin Gastroenterol Hepatol,2010,8(2):105
[12]SUZUKI H,NISHIZAWA T,HIBI T.Helicobacter pylori eradication therapy[J].Future Microbiol,2010,5(4):639
[13]ALFIZAH H,RUKMAN AH,NORAZAH A,et al.Ethnicity association of Helicobacter pylori virulence genotype and metronidazole susceptibility[J].World J Gastroenterol,2013,19(8):1283
[14]LIMA KS,ALBUQUERQUE W,ARANTES VN,et al.Helicobacter pylori and t(11; 18)(q21; q21)translocation in gastric malt lymphoma[J].Arq Gastroenterol,2014,51(2):84
[15]RADERER M,JÄGER G,BRUGGER S,et al.Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma[J].Oncology,2003,65(4):306
[16]AGUIAR-BUJANDA D,LLORCA-MÁRTINEZ I,RIVERO-VERA JC,et al.Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone[J].Hematol Oncol,2014,32(3):139

备注/Memo

备注/Memo:
#通信作者,女,1968年3月生,博士,主任医师,研究方向:消化内镜及消化疾病,E-mail:jiangxuan68@126.com
更新日期/Last Update: 2017-01-20